SKYE
Skye Bioscience·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SKYE fundamentals
Skye Bioscience (SKYE) released its earnings on Nov 10, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.32 (YoY -220.00%), met estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.32
-220.00%
Report date
Nov 10, 2025
SKYE Earnings Call Summary for Q3,2025
- Phase IIa Results Stand Out: Nimasimab + semaglutide delivered 3% additional weight loss (p=0.0372) with no safety issues.
- Durability Advantage: 18% weight regain vs. 50% for semaglutide alone, supporting maintenance potential.
- Higher Doses Key: PK/PD modeling shows efficacy improves with exposure; Phase IIb combo study to define optimal dose.
- CMC Progress: Scalable manufacturing and cost optimization on track for commercial readiness.
- Positive KOL Feedback: Physicians highlight nimasimab's differentiated mechanism and safety profile.
EPS
Revenue
Revenue & Expenses
Key Indicators
Skye Bioscience (SKYE) key financial stats and ratios, covering profitability, financial health, and leverage.
Skye Bioscience (SKYE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Skye Bioscience (SKYE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Skye Bioscience (SKYE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Skye Bioscience (SKYE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Skye Bioscience (SKYE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Skye Bioscience's latest dividend and current dividend yield?What does Skye Bioscience do and what are its main business segments?What were the key takeaways from Skye Bioscience's earnings call?What guidance did Skye Bioscience's management provide for the next earnings period?What is Skye Bioscience's gross profit margin?What is the revenue and EPS growth rate for Skye Bioscience year over year?What factors drove the changes in Skye Bioscience's revenue and profit?What is the market's earnings forecast for Skye Bioscience next quarter?
